Does BELIMUMAB Cause Therapy cessation? 298 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 298 reports of Therapy cessation have been filed in association with BELIMUMAB (BENLYSTA). This represents 1.1% of all adverse event reports for BELIMUMAB.
298
Reports of Therapy cessation with BELIMUMAB
1.1%
of all BELIMUMAB reports
2
Deaths
45
Hospitalizations
How Dangerous Is Therapy cessation From BELIMUMAB?
Of the 298 reports, 2 (0.7%) resulted in death, 45 (15.1%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 298 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which BELIMUMAB Alternatives Have Lower Therapy cessation Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID